Purpose: To describe the clinical outcome of a secondary Descemet membrane endothelial keratoplasty (DMEK) to manage poor visual outcome after Descemet stripping endothelial keratoplasty (DSEK).
Methods: Three eyes of 3 patients that underwent DSEK for Fuchs endothelial dystrophy showed fluctuating and/or poor visual outcome ranging from 20/80 (0.25) to 20/40 (0.5). In a secondary procedure, 16-22 months after the initial DSEK, the DSEK graft was removed and replaced by a DMEK graft. The clinical outcome was evaluated by comparing the pre- to postoperative best-corrected visual acuity (BCVA), Pentacam imaging, and biomicroscopy.
Results: All secondary DMEK procedures were uneventful. Three months after secondary DMEK, all eyes had a BCVA of 20/25 (0.8) or better. Pentacam analysis showed a virtually stable anterior corneal curvature in all cases, but among cases, the transplant exchange induced variable refractive change at the posterior corneal surface.
Conclusion: To manage DSEK cases with poor visual outcome, secondary DMEK may be a feasible procedure potentially resulting in full visual rehabilitation, as in primary DMEK. The presence of donor posterior stroma in DSEK, but not in DMEK grafts, may be a major factor in limiting the final BCVA in endothelial keratoplasty.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/ICO.0b013e3181cda01a | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Outcome of Endothelium-Outward Preloaded Descemet Membrane Endothelial Keratoplasty in Long-Term Dextran-Containing Transport Medium Preservation.
Cornea
January 2025
Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach/Saar, Germany.
Purpose: To analyze the clinical outcome of organ-cultured endothelium-outward preloaded DMEK (pDMEK) using the RAPID cartridge.
Methods: This prospective study included 80 eyes of 80 patients who received a pDMEK. Best-corrected visual acuity (BCVA), endothelial cell count (ECC), and central corneal thickness were measured preoperatively and 4 to 6 weeks, 3 months, 6 months, and 1 year postoperatively.
Outcomes and safety of Descemet's membrane endothelial keratoplasty (DMEK) as a surgical treatment for corneal endothelial dysfunction: A multicenter study.
J Fr Ophtalmol
January 2025
Service d'ophtalmologie, hôpital La Timone, 264, rue Saint-Pierre, 13005 Marseille, France.
Purpose: To analyze the outcomes and frequency of complications after Descemet's membrane endothelial keratoplasty (DMEK) and evaluate the parameters associated with the occurrence of these complications.
Methods: A multicenter retrospective study of 143 DMEK procedures performed consecutively by five surgeons between June 2018 and March 2021 was performed. Surgeon-specific surgical and graft characteristics were also assessed.
Prevalence and Severity of Corneal Guttata After Descemet Membrane Endothelial Keratoplasty.
Cornea
December 2024
Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach/Saar, Germany.
Purpose: The postoperative occurrence of corneal guttae (CG) in patients after Descemet membrane endothelial keratoplasty (DMEK) can lead to a significant reduction in visual acuity (VA) with the subsequent need for repeat DMEK. Therefore, the aim of this study was to analyze the prevalence and clinical significance of CG in transplanted corneas after DMEK.
Methods: The prevalence and progression of CG after DMEK of 1657 patients were examined using endothelial specular microscopy images.
[Glaucoma drainage devices: Indications, intraoperative management and postoperative follow-up].
Klin Monbl Augenheilkd
December 2024
Glaucoma drainage devices (GDD) are used for patients with secondary glaucoma, such as uveitic or neovascular glaucoma, which is uncontrolled under local therapy. They are also used in patients with conjunctival scarring, for example after a previous vitrectomy or after unsuccessful previous glaucoma surgery, such as trabeculectomy. They are also a treatment option for congenital glaucoma, aphakic glaucoma or for the treatment of iridocorneoendothelial syndromes.
View Article and Find Full Text PDFTen-Year Follow-Up After Descemet Membrane Endothelial Keratoplasty.
Cornea
October 2024
Department of Ophthalmology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf; and.
Article Synopsis
- The study investigates the long-term clinical outcomes (up to 10 years) of Descemet Membrane Endothelial Keratoplasty (DMEK) and Triple-DMEK procedures in patients with conditions like Fuchs endothelial dystrophy and pseudophakic bullous keratopathy.
- A total of 54 eyes were followed for at least 5 years, revealing significant improvements in best-corrected visual acuity post-surgery, though endothelial cell density decreased over time, independent of visual acuity.
- Findings suggest that while endothelial cell density declines, patients maintain good vision for a decade post-surgery, with stable corneal thickness and relatively low rates of graft failure and complications.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!